MEDICOPharmaceuticals
Medico Remedies Ltd — Profit & Loss Statement
₹32.76
-7.47%
Medico Remedies Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Unusual Items | 0.00 | 34000.00 | 0.00 | -0.19 Cr | -1.97 Cr |
| Total Unusual Items Excluding Goodwill | 0.00 | 34000.00 | 0.00 | -0.19 Cr | -1.97 Cr |
| Interest Income | 0.10 Cr | 0.09 Cr | 0.10 Cr | 0.07 Cr | 0.42 Cr |
| Diluted Average Shares | 8.30 Cr | 8.30 Cr | 8.30 Cr | 8.30 Cr | 8.30 Cr |
| Basic Average Shares | 8.30 Cr | 8.30 Cr | 8.30 Cr | 8.30 Cr | 8.30 Cr |
| Diluted EPS | 1.22 | 1.00 | 0.87 | 0.58 | 0.31 |
| Basic EPS | 1.22 | 1.00 | 0.87 | 0.58 | 0.31 |
| Diluted NI Availto Com Stockholders | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Net Income Common Stockholders | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Net Income Including Noncontrolling Interests | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Net Income Continuous Operations | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Tax Provision | 3.41 Cr | 3.04 Cr | 2.86 Cr | 1.67 Cr | — |
| Pretax Income | 13.50 Cr | 11.33 Cr | 10.10 Cr | 6.48 Cr | — |
| Other Non Operating Income Expenses | 2.69 Cr | 2.13 Cr | 3.95 Cr | 2.03 Cr | — |
| Special Income Charges | 0.00 | 34000.00 | 0.00 | -0.19 Cr | -1.97 Cr |
| Net Non Operating Interest Income Expense | -1.05 Cr | -0.73 Cr | -0.65 Cr | -0.59 Cr | — |
| Total Other Finance Cost | 0.30 Cr | 0.18 Cr | 0.17 Cr | 0.16 Cr | 0.13 Cr |
| Interest Expense Non Operating | 0.85 Cr | 0.64 Cr | 0.58 Cr | 0.51 Cr | — |
| Interest Income Non Operating | 0.10 Cr | 0.09 Cr | 0.10 Cr | 0.07 Cr | 0.42 Cr |
| Operating Income | 11.97 Cr | 10.03 Cr | 6.90 Cr | 5.31 Cr | — |
| Operating Expense | 17.61 Cr | 14.68 Cr | 18.87 Cr | 17.31 Cr | — |
| Other Operating Expenses | -0.10 Cr | 0.73 Cr | 0.01 Cr | 0.46 Cr | — |
| Depreciation And Amortization In Income Statement | 3.03 Cr | 2.88 Cr | 2.72 Cr | 2.22 Cr | — |
| Depreciation Income Statement | 3.03 Cr | 2.88 Cr | 2.72 Cr | 2.22 Cr | — |
| Selling General And Administration | 10.68 Cr | 6.77 Cr | 12.32 Cr | 11.86 Cr | 11.06 Cr |
| Selling And Marketing Expense | 6.25 Cr | 3.93 Cr | 9.60 Cr | 9.03 Cr | 8.30 Cr |
| General And Administrative Expense | 4.43 Cr | 2.84 Cr | 2.72 Cr | 2.83 Cr | 2.76 Cr |
| Gross Profit | 29.58 Cr | 24.71 Cr | 25.77 Cr | 22.62 Cr | — |
| Cost Of Revenue | 119.08 Cr | 118.60 Cr | 112.73 Cr | 95.73 Cr | — |
| Total Revenue | 148.66 Cr | 143.31 Cr | 138.50 Cr | 118.35 Cr | — |
| Operating Revenue | 148.66 Cr | 143.31 Cr | 138.50 Cr | 118.35 Cr | — |
| Tax Effect Of Unusual Items | 0.00 | 9130.74 | 0.00 | -0.05 Cr | — |
| Tax Rate For Calcs | 0.25 | 0.27 | 0.28 | 0.26 | — |
| Normalized EBITDA | 17.39 Cr | 14.85 Cr | 16.12 Cr | 11.62 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Reconciled Depreciation | 3.03 Cr | 2.88 Cr | 5.44 Cr | 4.44 Cr | — |
| Reconciled Cost Of Revenue | 119.08 Cr | 118.60 Cr | 112.73 Cr | 95.73 Cr | — |
| EBITDA | 17.39 Cr | 14.86 Cr | 16.12 Cr | 11.43 Cr | — |
| EBIT | 14.36 Cr | 11.98 Cr | 10.68 Cr | 6.99 Cr | — |
| Net Interest Income | -1.05 Cr | -0.73 Cr | -0.65 Cr | -0.59 Cr | — |
| Interest Expense | 0.85 Cr | 0.64 Cr | 0.58 Cr | 0.51 Cr | — |
| Normalized Income | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.96 Cr | — |
| Net Income From Continuing And Discontinued Operation | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Total Expenses | 136.69 Cr | 133.28 Cr | 131.60 Cr | 113.04 Cr | — |
| Other Special Charges | — | -34000.00 | 12000.00 | 0.04 Cr | — |
| Rent And Landing Fees | — | 0.00 | 0.07 Cr | 0.03 Cr | 0.00 |
| Rent Expense Supplemental | — | 0.00 | 0.07 Cr | 0.03 Cr | 0.00 |
| Write Off | — | — | 0.00 | 0.15 Cr | 1.97 Cr |
| Net Income Discontinuous Operations | — | — | — | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Medico Remedies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.